Oral Session 1-5D MM and myeloma related diseases

[OS1-5D-4] Seeking optimal treatment for TAFRO syndrome: A retrospective study from a multicenter registry

Shino Fujimoto¹, Hiroshi Kawabata¹, Yasufumi Masaki¹, Kazue Takai², Norifumi Tsukamoto³, Yasuhito Ishigaki⁴, Nozomu Kurose⁵, Masaru Kojima⁶, Shigeo Nakamura⁷, Tomohiro Kinoshita⁸, Sadao Aoki⁹ (1.Hematology and Immunology, Medicine, Kanazawa Medical University,Ishikawa , Japan, 2.Department of Hematology, Niigata City General Hospital, Niigata,Japan, 3.Department of Medicine and Clinical Science, Gunma University, Gunma, Japan, 4.Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan, 5.Department of Pathology and Medicine, Kanazawa Medical University, Ishikawa,Japan, 6.Department of Diagnostic Pathology, Dokkyo University , Tochigi, Japan, 7.Department of Pathology and Biological Response, Nagoya University , Aichi,Japan, 8.Hematology and Cell Therapy Aichi Cancer Center Hospitai , Aichi,Japan, 9.Department of Pathophysiology, Niigata University of Pharmacy, Niigata, Japan)